Skip to main content
Sartorius AG logo

Sartorius AG — Investor Relations & Filings

Ticker · SRT3 ISIN · DE0007165607 LEI · 529900EQV2DY4FOAMU38 F Manufacturing
Open in API
Filings indexed 392 across all filing types
Latest filing 2002-04-24 Earnings Release
Country DE Germany
Listing F SRT3

About Sartorius AG

https://www.sartorius.com/en

Sartorius is a leading international partner for the biopharmaceutical industry and life science research. The company provides a comprehensive portfolio of products and services that support the entire drug development and manufacturing process, from initial discovery to production. Key offerings include advanced solutions for filtration, fermentation, fluid management, cell analysis, and process analytics. The laboratory products division supplies essential equipment such as balances, pipettes, and water purification systems. Sartorius focuses on simplifying complex scientific processes to help customers translate discoveries into effective medicines more quickly and efficiently.

Recent filings

Filing Released Lang Actions
Sartorius AG deutsch
Earnings Release Classification · 100% confidence The document is an 'Ad-hoc-Mitteilung' (Ad-hoc announcement) dated April 24, 2002, detailing preliminary financial performance for the 1st Quarter 2002 (revenue growth, order intake comparison). It explicitly states that the full balance sheet and income statement figures for Q1 will be published later ('erst Ende Mai veröffentlicht'). This structure—a brief, immediate release of key performance indicators (KPIs) before the comprehensive report—is characteristic of an Earnings Release (ER). Although it mentions the final 2001 figures are being presented today at a press conference, the primary content focuses on the preliminary Q1 2002 results, making ER the most appropriate classification for this immediate financial highlight release. Q1 2002
2002-04-24 German
Sartorius AG english
Earnings Release Classification · 100% confidence The document is an 'Ad-hoc-announcement' dated March 4, 2002, detailing preliminary financial results for the year 2001, including increases in EBIT, EBITDA, revenue, and order intake. It explicitly mentions that the Supervisory Board will approve the annual financial statements on March 15, 2002, and the final numbers will be reported on April 24, 2002. This structure—a preliminary announcement of key financial highlights before the official release of the full report—is characteristic of an Earnings Release (ER). It is not the full Annual Report (10-K) or the comprehensive Interim Report (IR), but rather the initial summary of period results. FY 2001
2002-03-04 English
Sartorius AG deutsch
Earnings Release Classification · 100% confidence The document is an 'Ad-hoc-Mitteilung' (Ad-hoc announcement) dated March 4, 2002, detailing preliminary financial results for the full year 2001 (EBIT, EBITDA, Revenue, Order Intake). It explicitly mentions that the final figures will be published later at the 'Bilanzpressekonferenz' (Balance Sheet Press Conference) on April 24, 2002. Since this is an initial announcement of key financial highlights for a period, it fits the definition of an Earnings Release (ER). It is not the full Annual Report (10-K) or the comprehensive Interim Report (IR), but rather the preliminary summary release. FY 2001
2002-03-04 German
Sartorius AG
Board/Management Information Classification · 100% confidence The document is an 'Ad-hoc' announcement dated December 7, 2001, detailing immediate changes to the company's executive board (Vorstand). Specifically, it announces the appointment of Dr. Eric Janssens to the board and reassigns responsibilities for Mr. Michel Warter, effective January 1, 2002. This content directly relates to changes in senior management personnel. This aligns perfectly with the definition for Board/Management Information (MANG). The document is short and is a direct announcement, not a reference to a larger report.
2001-12-07 German
Sartorius AG 2. Teil
Regulatory Filings Classification · 95% confidence The document is labeled as an 'Ad-hoc-Meldung gemäß § 15 WpHG' (Ad-hoc announcement according to § 15 WpHG), which is a mandatory disclosure for German listed companies regarding significant, non-public information. The content discusses operational updates (new factory, capacity expansion via a new subsidiary BBITECH@MEDIT S.r.L.), changes in accounting standards (IAS adoption), and future outlook/guidance for revenue and EBIT for the current and next year (2002), including a planned IPO for Vivascience AG. This type of forward-looking guidance and significant operational update, released outside of a standard quarterly report, is characteristic of an Earnings Release (ER) or a general regulatory announcement. Since it provides specific financial expectations ('deutlich zweistellige Wachstumsrate', 'Steigerungsrate zu erwarten') but is structured as a brief, immediate disclosure rather than a comprehensive report (like a 10-K or IR), it fits best as an Earnings Release (ER) or a general Regulatory Filing (RNS). Given the focus on financial expectations and outlook, ER is a strong candidate. However, because it is explicitly an 'Ad-hoc-Meldung' and not explicitly titled as an 'Earnings Release' or 'Quarterly Report', and it covers strategic/operational news alongside financial outlook, the most appropriate general category for immediate, non-standard regulatory disclosures is RNS, or ER if the financial guidance is the primary focus. Since it contains significant financial guidance and outlook updates, ER is slightly more specific than RNS. Given the short length (2633 chars) and the nature of an ad-hoc disclosure, it functions as an immediate release of material information, which aligns closely with the function of an ER, even if it's not the full quarterly report.
2001-11-09 German
Sartorius AG 1. Teil
Earnings Release Classification · 100% confidence The document is a short, time-sensitive announcement labeled 'Ad-hoc-Meldung gemäß § 15 WpHG' (Ad-hoc announcement according to § 15 WpHG). It provides key financial highlights (order intake, revenue, EBIT) for the first nine months of 2001, comparing them to the previous year. This format, focusing on immediate release of key performance indicators for a specific period (nine months), strongly indicates an Earnings Release (ER), which typically precedes the full Interim Report (IR). Since it only contains highlights and is very brief (2565 chars), it fits the definition of an initial announcement of periodical financial results. 9M 2001
2001-11-09 German

Browse filings by year

24 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.